Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/04/2014US20140357630 Phenylacetic Acid Compound
12/04/2014US20140357629 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
12/04/2014US20140357626 Hetero-Bicyclic Derivatives As HCV Inhibitors
12/04/2014US20140357621 Organic Compounds
12/04/2014US20140357620 Method for administration of a gamma secretase inhibitor
12/04/2014US20140357619 Apparatus for applying health treatment.
12/04/2014US20140357612 Compounds for kinase modulation, and indications therefor
12/04/2014US20140357611 Compounds and methods of treating ocular disorders
12/04/2014US20140357610 Composition and method for affecting obesity and related conditions
12/04/2014US20140357609 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
12/04/2014US20140357607 Corticosteroid compositions
12/04/2014US20140357606 Organic compounds
12/04/2014US20140357605 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
12/04/2014US20140357604 Therapeutic Composition for Treating Cancers
12/04/2014US20140357603 Methods for Controlled Release Oral Dosage of a Vitamin D Compound
12/04/2014US20140357602 Combination Therapies For Treating Metabolic Disorders
12/04/2014US20140357601 Famciclovir and celecoxib combination therapy kit for functional somatic syndromes
12/04/2014US20140357600 Novel ester containing compositions and methods
12/04/2014US20140357599 Novel urea and thiourea derivatives
12/04/2014US20140357595 Methods of preventing and treating recurrence of a hepatitis c virus infection in a subject after the subject has received a liver transplant
12/04/2014US20140357592 Composition
12/04/2014US20140357587 Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/04/2014US20140357583 Sugar Extracts
12/04/2014US20140357582 Desrhamnosyl acteoside-containing olive extract
12/04/2014US20140357581 Method for regulating blood glucose level
12/04/2014US20140357580 Anti-microbial compositions
12/04/2014US20140357576 Methods for enhancement of muscle protein synthesis
12/04/2014US20140357571 Glutamine enriched nutritional composition for preterm infants
12/04/2014US20140357570 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
12/04/2014US20140357568 Method of Increasing Muscle Mass and Strength and Compositions Therefor
12/04/2014US20140357567 Methods for treating cancers using oral formulations of cytidine analogs
12/04/2014US20140357563 Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof
12/04/2014US20140357557 Cyclodextrin-based polymers for therapeutic delivery
12/04/2014US20140357555 Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
12/04/2014US20140357553 Nutritional composition for wound healing
12/04/2014US20140356814 Dental implant having enhanced early stability and method for manufacturing same
12/04/2014US20140356464 Organic emulsion comprising dha and epa
12/04/2014US20140356462 Muscle atrophy inhibitor
12/04/2014US20140356459 Micrornas and uses thereof
12/04/2014US20140356458 Treatment of sickle cell disease
12/04/2014US20140356457 Novel means and methods for the treatment of hearing loss and phantom hearing
12/04/2014US20140356456 Treating cancer with atr inhibitors
12/04/2014US20140356448 Treating prostate, ovarian, or breast cancer with a whole, leech saliva extract
12/04/2014US20140356444 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
12/04/2014US20140356443 Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component
12/04/2014US20140356439 Lipidated glycoprotein particles and methods of use
12/04/2014US20140356438 Peripherally administered viscous formulations
12/04/2014US20140356437 Corticosteroids for the Treatment of Joint Pain
12/04/2014US20140356434 Pharmaceutical formulation
12/04/2014US20140356433 Pharmaceutical Carrier and Drug Structure Using the Same
12/04/2014US20140356431 Oral administrable pharmaceutical composition
12/04/2014US20140356430 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
12/04/2014US20140356428 Tamper resistant dosage form with bimodal release profile
12/04/2014US20140356426 Tamper-resistant dosage form containing one or more particles
12/04/2014US20140356425 Composition and method for treating neurological disease
12/04/2014US20140356424 Composition for treatment or reduction of symptoms related to premenstrual syndrome (pms), premenstrual disphoric disorder (pmdd), premenopause, menopause or female hormonal disorders, in a pharmaceutical composition containing said form, and process for producing said pharmaceutical form and use of said composition
12/04/2014US20140356423 Formulations of lycopene in combination with bisphosphonates bone resorption inhibitors
12/04/2014US20140356422 Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
12/04/2014US20140356421 Antibody-Conjugated Double-Emulsion Nanocapsule and Preparation Methods Thereof
12/04/2014US20140356417 Modified drugs for use in liposomal nanoparticles
12/04/2014US20140356416 Liposomal drug encapsulation
12/04/2014US20140356414 Targeted Crosslinked Multilamellar Liposomes
12/04/2014US20140356413 Retinoid-liposomes for treating fibrosis
12/04/2014US20140356412 Non-Aqueous Patch
12/04/2014US20140356383 Administration of an anti-gcc antibody-drug conjugate and a dna damaging agent in the treatment of cancer
12/04/2014US20140356376 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356375 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356373 Methods and compositions for treating lupus
12/04/2014US20140356371 Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)
12/04/2014US20140356361 Repeated administration of non-immunosuppressive antigen specific immunotherapeutics
12/04/2014US20140356360 Piperazinyl derivatives for the treatment of cancer
12/04/2014US20140356352 COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
12/04/2014US20140356350 Combination therapy to prevent dcis formation and progression to breast cancer
12/04/2014US20140356341 Medication and treatment for disease
12/04/2014US20140356334 Methods for improved wound closure employing olivamine and endothelial cells
12/04/2014US20140356325 Novel 2'-c-methyl nucleoside derivative compounds
12/04/2014US20140356322 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
12/04/2014US20140356316 Amine polymers for use as bile acid sequestrants
12/04/2014US20140356315 Triblock copolymer and use therefor
12/04/2014US20140356313 Dermal protector
12/04/2014US20140356301 Galactolipids-Enriched Plant Extracts And The Uses Thereof
12/04/2014US20140356297 Oral compositions for absorption of phosphorous compounds
12/04/2014US20140356294 Dosage that is safeguarded from abuse
12/04/2014US20140356292 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
12/04/2014US20140356290 Methods for Therapeutic Renal Denervation
12/04/2014US20140356289 Multisomes: Encapsulated Droplet Networks
12/04/2014US20140356287 PLOD2 as a Target of Intervention for Sarcoma Metastasis
12/02/2014USRE45275 Fatty acid niacin conjugates and their uses
12/02/2014US8901357 Dibenzoyl peroxide derivatives, preparation method thereof and cosmetic or dermatological compositions containing same
12/02/2014US8901349 Ferric organic compounds, uses thereof and methods of making same
12/02/2014US8901345 Process for preparation of optically active diamine derivative salt
12/02/2014US8901316 Process for preparing aminoadamantyl carbamate derivatives
12/02/2014US8901314 Substituted pyrazoles as N-type calcium channel blockers
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901310 Tricyclic compounds, compositions, and methods
12/02/2014US8901307 Chemical compounds 251
12/02/2014US8901306 Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
12/02/2014US8901305 Aryl lactam kinase inhibitors
12/02/2014US8901303 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 7860